City of Hope to Present New Research at the AACR Annual Meeting
Mustang Bio and City of Hope’s chimeric antigen receptor T-cell (CAR-T) therapy for recurrent glioblastoma resulted in stable disease or better in half of the subjects in a phase 1 clinical trial, including one patient whose cancer has not recurred for more than five years.
City of Hope Launches First-of-its-Kind Mobile Cancer Prevention and Screening Program
City of Hope, TGen Researchers Develop Machine-Learning Tool to Detect Cancer Earlier via Liquid Biopsy
City of Hope appoints Kristin Higgins, M.D., as chief clinical officer at City of Hope Cancer Center Atlanta
City of Hope Research Reveals an Immune Cell That Can Attack Cancer
City of Hope Cancer Center, Children’s Oncology Group conduct largest trial
City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias
City of Hope Scientists Present Promising New Research at Annual Meeting
City of Hope Doctors and Scientists Present Innovative Research